| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.52B | +6.3% |
| Cost of Revenue | $3.44B | +6.8% |
| Gross Profit | $2.08B | +5.5% |
| R&D Expense | $206.0M | +1.0% |
| SG&A Expense | $1.23B | +4.1% |
| Operating Income | $622.0M | +6.3% |
| Interest Expense | $50.0M | -34.2% |
| Pre-tax Income | $440.0M | -13.9% |
| Income Tax | $85.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $944.0M | -30.0% |
| Accounts Receivable | $1.10B | +15.0% |
| Inventory | $799.0M | +14.1% |
| Current Assets | $3.01B | -4.7% |
| Total Assets | $7.95B | -3.9% |
| Current Liabilities | $1.59B | +14.3% |
| Long-term Debt | $1.88B | -23.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $596.0M | +10.8% |
| Investing Cash Flow | -$191.0M | -4.4% |
| Financing Cash Flow | -$790.0M | +7.6% |
| +1.2% |
| Net Income | $355.0M | -16.9% |
| EPS (Basic) | $1.97 | -16.9% |
| EPS (Diluted) | $1.96 | -16.6% |
| Total Liabilities |
| $4.45B |
| -11.9% |
| Stockholders' Equity | $3.49B | +8.6% |